Skip to main content

Advertisement

Table 2 Anti-CCP seropositivity of studied groups

From: Assessment of anti-cyclic citrullinated peptide in psoriatic arthritis

  PsA (n = 40) Psoriasis without arthritis (n = 40) RA (n = 40) Healthy controls (n = 40) P-value
Anti-CCP      
-negative n (%) 33 (82.5%) 40 (100%) 6 (15%) 40 (100%) <0.001
-positive n (%) 7 (17.5%) 0 34 (85%) 0  
  1. PsA: psoriatic arthritis, RA: rheumatoid arthritis